Scientific Reports (Sep 2021)

The gastric microbiota in patients with Crohn’s disease; a preliminary study

  • Jerzy Ostrowski,
  • Maria Kulecka,
  • Iwona Zawada,
  • Natalia Żeber-Lubecka,
  • Agnieszka Paziewska,
  • Katarzyna Graca-Pakulska,
  • Krzysztof Dąbkowski,
  • Karolina Skubisz,
  • Patrycja Cybula,
  • Filip Ambrożkiewicz,
  • Elżbieta Urasińska,
  • Michał Mikula,
  • Teresa Starzyńska

DOI
https://doi.org/10.1038/s41598-021-97261-z
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

Abstract The gastric microbiota in Crohn’s disease (CD) has not been studied. The purpose of the study was to evaluate differences of stomach microbiota between CD patients and controls. DNA was extracted from gastric mucosal and fluid samples, from 24 CD patients and 19 controls. 16S rRNA gene sequencing identified 1511 operational taxonomic units (OTUs), of which 239 passed the low abundance and low variance filters. All but one CD patients were HP negative. Fifteen bacterial phyla were identified in at least one mucosal or fluid site. Of these, Bacteroidota and Firmicutes accounted for 70% of all phyla. Proteobacteria, Actinobacteriota, and Fusobacteriota combined accounted for 27%. There was significant difference in the relative abundance of Bacteroidota, Proteobacteria, Fusobacteriota, and Campilobacterota between CD patients and controls only in gastric corpus samples. In gastric liquid, there was a significant difference only in Actinobacteriota. Pairwise comparison identified 67 differentially abundant OTUs in at least one site. Of these, 13 were present in more than one comparison, and four differentiating OTUs (Neisseriaceae, Neisseria, Absconditabacteriales, and Microbacteriaceae) were identified at all tested sites. The results reveal significant changes in gastric microbial profiles (beta diversity, phylum, and individual taxa levels) between H. pylori-negative CD patients and controls.